Monitoring the elimination of leprosy in Brazil

被引:0
作者
Andrade, V
Sabroza, PC
de Albuquerque, MDM
Motta, CD
机构
[1] Minist Hlth, Brazilia, Brazil
[2] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Samuel Pessoa Dept, Rio De Janeiro, Brazil
[3] Univ Fed Pernambuco, Dept Clin Med, Fundacao Oswaldo Cruz, Collect Hlth Studies Dept, Recife, PE, Brazil
[4] Dermatol Sanitaria RJ, Rio De Janeiro, Brazil
关键词
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A decreasing trend in the prevalence rate of leprosy was reached in Brazil only after the introduction of the World Health Organization multidrug therapy (WHO/MDT) program in 1990, This paper analyzes leprosy morbidity indicators and the prevalence rate, and their utilization in monitoring the progress of leprosy elimination in Brazil. Since these indicators are modified by changes in health service procedures comparing prevalence rates from different endemic countries or current prevalence rates with old ones from the same endemic region needs careful attention. The current official prevalence rate of 6.72/10,000 inhabitants in Brazil could be considered high when compared with rates from other countries, but it is important to remember that defaulters and patients being treated with old regimens are kept on the active registers in Brazil, while in most other endemic countries they are not.
引用
收藏
页码:457 / 463
页数:7
相关论文
共 10 条
  • [1] Andrade V, 1997, Acta Leprol, V10, P131
  • [2] ANDRADE VLG, 1996, THESIS O CRUZ FDN RI
  • [3] ANDRADE VLG, 1997, PNEUMOL SANIT, V5, P30
  • [4] GONCALVES A, 1987, Boletin de la Oficina Sanitaria Panamericana, V102, P246
  • [5] KLEINMAN JC, 1976, INFANT MORTALITY STA, V2
  • [6] *MIN SAUD BRAS, 1997, UNPUB AV EP OP PROGR
  • [7] *MIN SAUD BRAS, 1994, UNPUB INSTR AV PROGR
  • [8] *MIN SAUD BRAS, 1984, GUIA PAR CONTR HANS
  • [9] *MIN SAUD BRAS, 1994, GUIA CONTR HANS BRAS
  • [10] *WHO, 1996, WHO WKLY EPIDEMIOL R, V20, P149